Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.

MLA

Louis, Chrystal U., et al. “Antitumor Activity and Long-Term Fate of Chimeric Antigen Receptor-Positive T Cells in Patients with Neuroblastoma.” Blood, vol. 118, no. 23, Dec. 2011, pp. 6050–56. EBSCOhost, https://doi.org/10.1182/blood-2011-05-354449.

APA

Louis, C. U., Savoldo, B., Dotti, G., Pule, M., Yvon, E., Myers, G. D., Rossig, C., Russell, H. V., Diouf, O., Liu, E., Liu, H., Wu, M.-F., Gee, A. P., Mei, Z., Rooney, C. M., Heslop, H. E., & Brenner, M. K. (2011). Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood, 118(23), 6050–6056. https://doi.org/10.1182/blood-2011-05-354449

Chicago

Louis, Chrystal U, Barbara Savoldo, Gianpietro Dotti, Martin Pule, Eric Yvon, G Doug Myers, Claudia Rossig, et al. 2011. “Antitumor Activity and Long-Term Fate of Chimeric Antigen Receptor-Positive T Cells in Patients with Neuroblastoma.” Blood 118 (23): 6050–56. doi:10.1182/blood-2011-05-354449.